During the past decade, Pretoria Urology Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pretoria Urology Hospital" are "Prostate Cancer" (2 trials), "Female Stress Incontinence" (1 trials), "Pelvic Organ Prolapse" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Pretoria Urology Hospital" in a lesser frequency.

Most popular intervention types in "Pretoria Urology Hospital" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (2 trials), "Docetaxel" (1 trials), "Elevate PC" (1 trials), "Lenalidomide" (1 trials) and "Mini Arc Pro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pretoria Urology Hospital" are 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pretoria Urology Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pretoria Urology Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pretoria Urology Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".